🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 774.83 +0.7% NASDAQ 100: 756.20 +0.9% Dow Jones: 534.08 -0.5%

Quantessence Capital - Q4 2025 13F Filings

QU

Quantessence Capital LLC

CIK: 0002009590
Address: New York New York 228 Park Ave. S Pmb 137068
$8.65 M
Portfolio Value
16
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 08/14/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. PANW Palo Alto Networks
+$1.04 M
2. AVGO Broadcom
+$1.02 M
3. WMT Walmart
+$1 M
4. LULU Lululemon Athletica
+$986,474
5. ON On Semiconductor Corporation
+$932,896

Top Sells

Q4 2025
1. WNS Wns (Holdings) Limited
−$24.97 M
2. VRNA Verona Pharma PLC
−$11.76 M
3. GOOG Alphabet
−$9.07 M
4. META Meta Platforms
−$8.11 M
5. ALNY Alnylam Pharmaceuticals
−$7.24 M

Asset Allocation

Stocks/ETFs
-97.29%
$8.57 M 99.10%
Options
$0 0.00%
Debt
$0 0.00%
Other
+100.00%
$77,856 0.90%

Sector Allocation (Stocks)

Quantessence Capital Q4 2025 Filing Summary

Quantessence Capital LLC filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 8.65 M reflecting a -97.26% change from the prior quarter, spanning 16 assets. The top 10 holdings comprised 93.2% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 15 new positions and 173 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Quantessence Capital’s Q4 2025 Filing

Quantessence Capital submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Quantessence Capital reported a managed portfolio value of 8.65 M, consisting of 16 individual positions.

This page displays the raw filing documents. To see which stocks Quantessence Capital bought or sold during Q4 2025, please visit Quantessence Capital's Portfolio Analysis page.